Skip to main content
CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
126.69
+4.93 (4.05%)
At close: Dec 5, 2025

CSL Limited Revenue

In the fiscal year ending June 30, 2025, CSL Limited had annual revenue of $15.56B with 5.12% growth. CSL Limited had revenue of $7.08B in the half year ending June 30, 2025, with 15.49% growth.

Revenue
15.56B
Revenue Growth
+5.12%
P/S Ratio
3.79
Revenue / Employee
520.26K
Employees
29,904
Market Cap
58.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202515.56B758.00M5.12%
Jun 30, 202414.80B1.49B11.19%
Jun 30, 202313.31B2.75B26.02%
Jun 30, 202210.56B252.00M2.44%
Jun 30, 202110.31B1.16B12.67%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Mid-Atlantic Home Health Network 27.00M
Revenue Rankings

CSL Limited News

More News